← Evidence map

ArticleMovement disorders clinical practice2026

Reply to: Deprescribing after DBS in Dystonia: Promise, Pitfalls, and a Path Forward.

Marcela A Montiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41810489